Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroporation-mediated gene therapy.

Yoshitaka Isaka1, Enyu Imai

  • 1Osaka University Graduate School of Medicine, Divisions of Advanced Technology for Transplantation and Nephrology, Suita, Osaka 565-0871, Japan. isaka@att.med.osaka-u.ac.jp

Expert Opinion on Drug Delivery
|September 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of the Japan Kidney Association-Pemafibrate Intervention for Chronic Kidney Disease patients Study (JKAPI-CKD Study).

Clinical kidney journal·2026
Same author

Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus.

Clinical and experimental nephrology·2026
Same author

Predicting Lifetime Risk of Kidney Failure Using Age and a Single eGFR Measurement.

Journal of clinical medicine·2026
Same author

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure.

Nature medicine·2025
Same author

Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Dapagliflozin for the Treatment of Collagenofibrotic Glomerulopathy.

Internal medicine (Tokyo, Japan)·2025

In vivo electroporation significantly improves non-viral gene transfer across various tissues. This safe and effective method shows promise for gene therapy, with clinical trials for melanoma now underway.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Science

Background:

  • Non-viral gene transfer methods are crucial for developing novel therapeutic strategies.
  • Electroporation offers a promising approach to enhance gene delivery efficiency.
  • Previous studies have highlighted the potential of electroporation in various preclinical models.

Purpose of the Study:

  • To review the principles and applications of in vivo electroporation for gene therapy.
  • To discuss the range of target tissues successfully utilized with electroporation.
  • To highlight the progression of electroporation from preclinical research to clinical application.

Main Methods:

  • Review of existing literature on in vivo electroporation techniques.
  • Analysis of studies demonstrating electroporation's efficacy in different tissues and disease models.

Related Experiment Videos

  • Examination of data supporting the transition to clinical trials.

    • Main Results:

    • In vivo electroporation markedly enhances non-viral gene transfer efficiency.
    • Electroporation has proven safe and effective in diverse tissues like muscle, tumors, kidney, liver, and skin.
    • Numerous successful applications in various disease models have been documented.

    Conclusions:

    • Electroporation is a versatile and effective tool for in vivo gene therapy.
    • Positive preclinical results have led to the initiation of clinical studies, notably for malignant melanoma.
    • Further research and clinical application are warranted to fully realize the potential of electroporation in gene therapy.